Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anemil Trial: Interleukine-2 for Active Warm Hemolytic Anemia
NCT02389231Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2017
- Primary completion
- Nov 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in warm autoimmune hemolytic anemia (wAIHA), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started May 2017; status: terminated.
02
Drugs
aldesleukin
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on NCT02389231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389231.